Axel Capital Management’s Johnson & Johnson JNJ Stock Holding History

Axel Capital Management’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-7,400	Closed	-$962K	–	20
2017 Q3	$962K	Hold	7,400	–	–	0.63%	17
2017 Q2	$979K	Hold	7,400	–	–	0.48%	14
2017 Q1	$922K	Hold	7,400	–	–	0.67%	11
2016 Q4	$852K	Hold	7,400	–	–	0.67%	12
2016 Q3	$874K	Hold	7,400	–	–	0.67%	11
2016 Q2	$898K	Hold	7,400	–	–	0.8%	12
2016 Q1	$801K	Hold	7,400	–	–	0.43%	13
2015 Q4	$760K	Hold	7,400	–	–	0.43%	17
2015 Q3	$691K	Hold	7,400	–	–	0.42%	22
2015 Q2	$721K	Hold	7,400	–	–	0.51%	26
2015 Q1	$744K	Buy	7,400 +7,000	+1,750%	+$712K	0.52%	26
2014 Q4	$42K	Hold	400	–	–	0.04%	32
2014 Q3	$43K	Hold	400	–	–	0.04%	28
2014 Q2	$42K	Buy	400 +130	+48%	+$13.1K	0.08%	26
2014 Q1	$26K	Hold	270	–	–	0.06%	35
2013 Q4	$25K	Hold	270	–	–	0.11%	25
2013 Q3	$23K	Hold	270	–	–	0.6%	16
2013 Q2	$23K	Buy	+270	New	+$22.9K	2.87%	18

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Axel Capital Management's JNJ Position: Q4 2017 in Review

Axel Capital Management sold out of Johnson & Johnson (JNJ) in Q4 2017, closing a stake of 7,400 shares — an estimated $962K sold.

Axel Capital Management first reported a position in JNJ in Q2 2013 and held it in 18 quarters. The position peaked at $979K in Q2 2017. 2,623 funds tracked by Wall St. Rank hold JNJ as of Q4 2017.

Axel Capital Management reported no remaining Johnson & Johnson position as of Q4 2017 after selling out during the quarter.
Axel Capital Management sold 7,400 Johnson & Johnson shares in Q4 2017, an estimated $962K.
Axel Capital Management first reported a position in Johnson & Johnson in Q2 2013 and held it in 18 quarters.
Axel Capital Management's Johnson & Johnson position peaked at $979K in Q2 2017.
2,623 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2017.

Based on Axel Capital Management's 13F filing for Q4 2017, filed 31 Jan 2018.